Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers
2024 · Clinical Proteomics · 7 citations
https://doi.org/10.1186/s12014-024-09492-7
R
Rachel Cohen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
1.0K
Citations
16
h-index
18
i10-index
Rachel Cohen is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment. The author has an h-index of 16, co-authored 43 publications.
Papers by this author
worksP1.08D.02 Survival after Salvage Treatment Following Durvalumab Consolidation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
2024 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2024.09.333
Real World Radiographic Response Rates and Pre-Operative Attrition in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Neoadjuvant Chemoimmunotherapy
2025 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2025.06.3644
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat